» Articles » PMID: 30806066

In Vitro Cytotoxic Activity of Clinacanthus Nutans Leaf Extracts Against HeLa Cells

Overview
Specialty Oncology
Date 2019 Feb 27
PMID 30806066
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study was conducted to investigate the antiproliferative activity of extracts of Clinacanthus nutans leaves against human cervical cancer (HeLa) cells. Methods: C. nutans leaves were subjected to extraction using 80% methanol or water. The methanol extract was further extracted to obtain hexane, dichloromethane (DCM), and aqueous fractions. The antiproliferative activity of the extracts against HeLa cells was determined. The most cytotoxic extract was furthered analyzed by apoptosis and cell cycle assays, and the phytochemical constituents were screened by gas chromatography-mass spectrometry (GC-MS). Results: All of the extracts were antiproliferative against HeLa cells, and the DCM fraction had the lowest IC50 value of 70 μg/mL at 48 h. Microscopic studies showed that HeLa cells exposed to the DCM fraction exhibited marked morphological features of apoptosis. The flow cytometry study also confirmed that the DCM fraction induced apoptosis in HeLa cells, with cell cycle arrest at the S phase. GC-MS analysis revealed the presence of at least 28 compounds in the DCM fraction, most of which were fatty acids. Conclusion: The DCM fraction obtained using the extraction method described herein had a lower IC50 value than those reported in previous studies that characterized the anticancer activity of C. nutans against HeLa cells.

Citing Articles

Fractionation, identification of chemical constituents, and biological properties of cashew ( L.) leaf extracts.

Pham D, Truong D, Tran Q, Ho Q, Nguyen T, Nguyen T Food Sci Nutr. 2023; 11(12):7996-8008.

PMID: 38107119 PMC: 10724627. DOI: 10.1002/fsn3.3718.


A Narrative Review on the Phytochemistry, Pharmacology and Therapeutic Potentials of (Burm. f.) Lindau Leaves as an Alternative Source of Future Medicine.

Chia T, Gan C, Murugaiyah V, Hashmi S, Fatima T, Ibrahim L Molecules. 2022; 27(1).

PMID: 35011371 PMC: 8746928. DOI: 10.3390/molecules27010139.


Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.

Nordin F, Pearanpan L, Chan K, Kumolosasi E, Yong Y, Shaari K PLoS One. 2021; 16(8):e0256012.

PMID: 34379689 PMC: 8357171. DOI: 10.1371/journal.pone.0256012.


Recent Advancement in Anticancer Activity of (Burm. f.) Lindau.

Lin C, Chen H, Lung C, Chen H Evid Based Complement Alternat Med. 2021; 2021:5560502.

PMID: 34135980 PMC: 8175158. DOI: 10.1155/2021/5560502.


Dichloromethane fraction of Moringa oleifera leaf methanolic extract selectively inhibits breast cancer cells (MCF7) by induction of apoptosis via upregulation of Bax, p53 and caspase 8 expressions.

Mohd Fisall U, Ismail N, Adebayo I, Arsad H Mol Biol Rep. 2021; 48(5):4465-4475.

PMID: 34086162 DOI: 10.1007/s11033-021-06466-y.


References
1.
Yong Y, Tan J, Teh S, Mah S, Ee G, Chiong H . Clinacanthus nutans Extracts Are Antioxidant with Antiproliferative Effect on Cultured Human Cancer Cell Lines. Evid Based Complement Alternat Med. 2013; 2013:462751. PMC: 3600186. DOI: 10.1155/2013/462751. View

2.
Huang J, Zhou L, Xu H, Li W . Insecticidal and cytotoxic activities of extracts of Cacalia tangutica and its two active ingredients against Musca domestica and Aedes albopictus. J Econ Entomol. 2009; 102(4):1444-7. DOI: 10.1603/029.102.0407. View

3.
Gao Z, Maloney D, Dedkova L, Hecht S . Inhibitors of DNA polymerase beta: activity and mechanism. Bioorg Med Chem. 2008; 16(8):4331-40. DOI: 10.1016/j.bmc.2008.02.071. View

4.
Quah S, Chin J, Akowuah G, Khalivulla S, Yeong S, Sabu M . Cytotoxicity and cytochrome P450 inhibitory activities of Clinacanthus nutans. Drug Metab Pers Ther. 2017; 32(1):59-65. DOI: 10.1515/dmpt-2016-0034. View

5.
Siew Y, Zareisedehizadeh S, Seetoh W, Neo S, Tan C, Koh H . Ethnobotanical survey of usage of fresh medicinal plants in Singapore. J Ethnopharmacol. 2014; 155(3):1450-66. DOI: 10.1016/j.jep.2014.07.024. View